NCT06222099

The HEARTFELT Study

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2025-10-23Est. Completion: 2026-12-31

Enrollment target: 1,500 participants

Locations

Baptist Health, Little Rock, Arkansas, United States
HealthArc, Hackensack, New Jersey, United States
Connect America, Bala-Cynwyd, Pennsylvania, United States

Contact

WH Wilson Tang, MDusa.trial@hftech.org +441223 967250

Amparito Cunningham, MD. MPH.amparito@hftech.org 6176425062

Other microbiome trials you might be interested in

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) AmyloidosisPhase 1Recruiting

AL Amyloidosis

The purpose of this study is assess safety, safest dose, and effectiveness of venetoclax in combination with dexamethaso…

Birmingham, United StatesEst. completion Sep 2027

View Trial →

Effect of a Focused Point-of-care Ultrasonography Screening Protocol in Hospitalized PatientsRecruiting

Heart Failure, CongestiveRenal Failure Acute ChronicLiver CirrhosisSepsisEdema, PulmonaryEstablish a Real-time Focused Ultrasound Examination Protocol for Routine Assessment of Hospitalized PatientsEdema

This research project aims to establish a real-time focused ultrasound examination protocol for routine assessment of ho…

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.